Publications 2025

Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-025-07330-y, PubMed 40397137

Lindland K, Juzeniene A (2025)
Cytotoxicity of ²¹²Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models
EJNMMI Radiopharm Chem, 10 (1), 58
DOI 10.1186/s41181-025-00382-3, PubMed 40885785

Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB (2025)
Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
Mol Cancer Ther, 24 (9), 1415-1427
DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114

Liukaityte R, Stenberg VY, Kleinauskas A, Juzenas P, Urbanucci A, Juzeniene A (2025)
Combination of PSMA targeting alpha-emitting radioligand [²¹²Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models
Med Oncol, 42 (8), 362
DOI 10.1007/s12032-025-02925-9, PubMed 40694184

Song L, Kostas M, Laerdahl JK, Skálová M, Janská T, Juzeniene A, Ræstad S, Krivokapic A, Kalantzopoulos GN, Soltes J, Vlk M, Kozempel J, Hassfjell S, Wesche J (2025)
Preparation and Characterization of an Engineered FGF1 Conjugated to ¹⁶¹Tb for Targeting of FGFRs
ACS Omega, 10 (6), 5730-5743
DOI 10.1021/acsomega.4c09179, PubMed 39989790

Publications 2024

Lindland K, Malenge MM, Li RG, Wouters R, Bønsdorff TB, Juzeniene A, Dragovic SM (2024)
Antigen targeting and anti-tumor activity of a novel anti-CD146 ²¹²Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma
Sci Rep, 14 (1), 25941
DOI 10.1038/s41598-024-76778-z, PubMed 39472474

Sioud M, Juzeniene A, Sæbøe-Larssen S (2024)
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens
Vaccines (Basel), 12 (6)
DOI 10.3390/vaccines12060624, PubMed 38932353

Publications 2023

Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
Editorial: Targeted alpha particle therapy in oncology
Front Med (Lausanne), 10, 1165747
DOI 10.3389/fmed.2023.1165747, PubMed 36960341

Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE (2023)
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
Int J Epidemiol, 52 (3), 887-898
DOI 10.1093/ije/dyac223, PubMed 36413027

Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
Dual targeting with ²²⁴Ra/²¹²Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936

Kvassheim M, Tornes AJK, Juzeniene A, Stokke C, Revheim MR (2023)
Imaging of ²¹²Pb in mice with a clinical SPECT/CT
EJNMMI Phys, 10 (1), 47
DOI 10.1186/s40658-023-00571-6, PubMed 37603123

Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nat Commun, 14 (1), 3375
DOI 10.1038/s41467-023-39097-x, PubMed 37291203

Publications 2022

Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand ²¹²Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766

Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
Targeted alpha therapy with the ²²⁴Ra/²¹²Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
Front Med (Lausanne), 9, 1058863
DOI 10.3389/fmed.2022.1058863, PubMed 36507500

Publications 2021

Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancers (Basel), 13 (4)
DOI 10.3390/cancers13040779, PubMed 33668474

Li RG, Lindland K, Tonstad SK, Bønsdorff TB, Juzeniene A, Westrøm S, Larsen RH (2021)
Improved Formulation of ²²⁴Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP
Pharmaceutics, 13 (5)
DOI 10.3390/pharmaceutics13050634, PubMed 33946852

Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
Calcium Carbonate Microparticles as Carriers of ²²⁴Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Curr Radiopharm, 14 (2), 145-153
DOI 10.2174/1874471013666201201102056, PubMed 33261548

Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
Evaluation of the PSMA-Binding Ligand ²¹²Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
Int J Mol Sci, 22 (9)
DOI 10.3390/ijms22094815, PubMed 34062920

Publications 2020

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol, 12, 193-202
DOI 10.2147/CLEP.S241249, PubMed 32110111

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
Clin Epidemiol, 12, 1389-1401
DOI 10.2147/CLEP.S269446, PubMed 33376408

Grigalavicius M, Mastrangelopoulou M, Arous D, Juzeniene A, Ménard M, Skarpen E, Berg K, Theodossiou TA (2020)
Photodynamic Efficacy of Cercosporin in 3D Tumor Cell Cultures
Photochem Photobiol, 96 (3), 699-707
DOI 10.1111/php.13257, PubMed 32125700

Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2020)
Combinatorial CAR design improves target restriction
J Biol Chem, 296, 100116
DOI 10.1074/jbc.RA120.016234, PubMed 33234592

Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
Calibration of sodium iodide detectors and reentrant ionization chambers for ²¹²Pb activity in different geometries by HPGe activity determined samples
Appl Radiat Isot, 166, 109362
DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756

Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
In situ Generated ²¹²Pb-PSMA Ligand in a ²²⁴Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
Curr Radiopharm, 13 (2), 130-141
DOI 10.2174/1874471013666200511000532, PubMed 32389119

Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [²¹² Pb]Pb-NG001 for prostate cancer
J Labelled Comp Radiopharm, 63 (3), 129-143
DOI 10.1002/jlcr.3825, PubMed 31919866

Publications 2019

Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE (2019)
Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study
BMJ Open, 9 (2), e025246
DOI 10.1136/bmjopen-2018-025246, PubMed 30787091

Publications 2018

Juzeniene A, Bernoulli J, Suominen M, Halleen J, Larsen RH (2018)
Antitumor Activity of Novel Bone-seeking, α-emitting ²²⁴Ra-solution in a Breast Cancer Skeletal Metastases Model
Anticancer Res, 38 (4), 1947-1955
DOI 10.21873/anticanres.12432, PubMed 29599310

Publications 2017

Gaware VS, Håkerud M, Juzeniene A, Høgset A, Berg K, Másson M (2017)
Endosome Targeting meso-Tetraphenylchlorin-Chitosan Nanoconjugates for Photochemical Internalization
Biomacromolecules, 18 (4), 1108-1126
DOI 10.1021/acs.biomac.6b01670, PubMed 28245649

Pudroma X, Duoji G, Grigalavicius M, Jie D, Juzeniene A (2017)
Molecular Mechanisms of UVA-Induced Melanoma
J Environ Pathol Toxicol Oncol, 36 (3), 217-228
DOI 10.1615/JEnvironPatholToxicolOncol.2017020213, PubMed 29283335

Publications 2016

Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, Garland CF, Holick MF (2016)
Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?
Dermatoendocrinol, 8 (1), e1187349
DOI 10.1080/19381980.2016.1187349, PubMed 27489574

Grigalavicius M, Iani V, Juzeniene A (2016)
Layer Thickness of SPF 30 Sunscreen and Formation of Pre-vitamin D
Anticancer Res, 36 (3), 1409-15
PubMed 26977044

Grigalavicius M, Juraleviciute M, Kwitniewski M, Juzeniene A (2016)
The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells
Photodiagnosis Photodyn Ther, 17, 29-34
DOI 10.1016/j.pdpdt.2016.10.008, PubMed 27777143

Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB (2016)
Phototherapy and vitamin D
Clin Dermatol, 34 (5), 548-55
DOI 10.1016/j.clindermatol.2016.05.004, PubMed 27638432

Juzeniene A, Grigalavicius M, Ma LW, Juraleviciute M (2016)
Folic acid and its photoproducts, 6-formylpterin and pterin-6-carboxylic acid, as generators of reactive oxygen species in skin cells during UVA exposure
J Photochem Photobiol B, 155, 116-21
DOI 10.1016/j.jphotobiol.2016.01.001, PubMed 26780587

Publications 2015

Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MAN (2015)
Supramolecular nanoscale assemblies for cancer diagnosis and therapy
J Control Release, 213, 152-167
DOI 10.1016/j.jconrel.2015.06.034, PubMed 26160308

Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
Vitamin D and ultraviolet phototherapy in Caucasians
J Photochem Photobiol B, 147, 69-74
DOI 10.1016/j.jphotobiol.2015.03.009, PubMed 25846579

Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
Daily, seasonal, and latitudinal variations in solar ultraviolet A and B radiation in relation to vitamin D production and risk for skin cancer
Int J Dermatol, 55 (1), e23-8
DOI 10.1111/ijd.13065, PubMed 26547141

Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
Scand J Public Health, 43 (3), 324-30
DOI 10.1177/1403494815572206, PubMed 25740614

Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
Anticancer Res, 35 (2), 1171-80
PubMed 25667508

Publications 2014

Juzeniene A, Grigalavicius M, Baturaite Z, Moan J (2014)
Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves
Int J Hyg Environ Health, 217 (8), 839-44
DOI 10.1016/j.ijheh.2014.06.002, PubMed 25023193

Moan J, Grigalavicius M, Baturaite Z, Dahlback A, Juzeniene A (2014)
The relationship between UV exposure and incidence of skin cancer
Photodermatol Photoimmunol Photomed, 31 (1), 26-35
DOI 10.1111/phpp.12139, PubMed 25213656

Publications 2013

Grigalavicius M, Juzeniene A, Baturaite Z, Dahlback A, Moan J (2013)
Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma
Dermatoendocrinol, 5 (1), 150-8
DOI 10.4161/derm.22941, PubMed 24494048

Juzeniene A, Iani V, Moan J (2013)
Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid
Photodiagnosis Photodyn Ther, 10 (4), 538-45
DOI 10.1016/j.pdpdt.2013.05.008, PubMed 24284108

Juzeniene A, Nizauskaite Z (2013)
Photodegradation of cobalamins in aqueous solutions and in human blood
J Photochem Photobiol B, 122, 7-14
DOI 10.1016/j.jphotobiol.2013.03.001, PubMed 23558034

Juzeniene A, Thu Tam TT, Iani V, Moan J (2013)
The action spectrum for folic acid photodegradation in aqueous solutions
J Photochem Photobiol B, 126, 11-6
DOI 10.1016/j.jphotobiol.2013.05.011, PubMed 23892004

Moan J, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
Cutaneous malignant melanoma incidence rates in Norway
Scand J Public Health, 41 (4), 336-9
DOI 10.1177/1403494813479216, PubMed 23439631

Moan J, Grigalavicius M, Baturaite Z, Juzeniene A, Dahlback A (2013)
North-South gradients of melanomas and non-melanomas: A role of vitamin D?
Dermatoendocrinol, 5 (1), 186-91
DOI 10.4161/derm.23791, PubMed 24494053

Moan JE, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
Sunbed use and cutaneous melanoma in Norway
Scand J Public Health, 41 (8), 812-7
DOI 10.1177/1403494813496601, PubMed 23907734

Orlova T, Moan J, Lagunova Z, Aksnes L, Terenetskaya I, Juzeniene A (2013)
Increase in serum 25-hydroxyvitamin-D3 in humans after sunbed exposures compared to previtamin D3 synthesis in vitro
J Photochem Photobiol B, 122, 32-6
DOI 10.1016/j.jphotobiol.2013.03.006, PubMed 23591142

Publications 2012

Juzeniene A, Grant WB, Moan JE (2012)
Reply to "Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials"
Scand J Infect Dis, 44 (9), 712-3
DOI 10.3109/00365548.2012.658580, PubMed 22385298

Juzeniene A, Moan J (2012)
Beneficial effects of UV radiation other than via vitamin D production
Dermatoendocrinol, 4 (2), 109-17
DOI 10.4161/derm.20013, PubMed 22928066

Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
Melanoma Res, 22 (6), 460-5
DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822

Uzdensky A, Kristiansen B, Moan J, Juzeniene A (2012)
Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study
Biochim Biophys Acta, 1820 (7), 795-803
DOI 10.1016/j.bbagen.2012.03.008, PubMed 22484521

Publications 2011

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011)
Photodynamic therapy of cancer: an update
CA Cancer J Clin, 61 (4), 250-81
DOI 10.3322/caac.20114, PubMed 21617154

Grant WB, Juzeniene A, Lagunova Z, Porojnicu AC, Moan JE (2011)
Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer
Int J Cancer, 128 (9), 2249-50
DOI 10.1002/ijc.25552, PubMed 20626044

Juzeniene A, Brekke P, Dahlback A, Andersson-Engels S, Reichrath J, Moan K, Holick MF, Grant WB, Moan J (2011)
Solar radiation and human health
Rep. Prog. Phys., 74 (6), 066701
DOI 10.1088/0034-4885/74/6/066701

Juzeniene A, Micu E, Porojnicu AC, Moan J (2011)
Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway
J Eur Acad Dermatol Venereol, 26 (7), 821-7
DOI 10.1111/j.1468-3083.2011.04162.x, PubMed 21707773

Micu E, Juzeniene A, Moan J (2011)
Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway
J Eur Acad Dermatol Venereol, 25 (12), 1444-9
DOI 10.1111/j.1468-3083.2011.04023.x, PubMed 21995584

Mikolajewska P, Rømoen OT, Martinsen OG, Iani V, Moan J, Grimnes S, Juzeniene A (2011)
Bioimpedance for pain monitoring during cutaneous photodynamic therapy: Preliminary study
Photodiagnosis Photodyn Ther, 8 (4), 307-13
DOI 10.1016/j.pdpdt.2011.06.001, PubMed 22122917

Moan J, Baturaite Z, Juzeniene A, Porojnicu AC (2011)
Vitamin D, sun, sunbeds and health
Public Health Nutr, 15 (4), 711-5
DOI 10.1017/S1368980011002801, PubMed 22017922

Moan J, Baturaite Z, Porojnicu AC, Dahlback A, Juzeniene A (2011)
UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden
Photochem Photobiol Sci, 11 (1), 191-8
DOI 10.1039/c1pp05215b, PubMed 21986949

Moan J, Nielsen KP, Juzeniene A (2011)
Immediate pigment darkening: its evolutionary roles may include protection against folate photosensitization
FASEB J, 26 (3), 971-5
DOI 10.1096/fj.11-195859, PubMed 22159146

Pudroma X, Juzeniene A, Ma LW, Iani V, Moan J (2011)
Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes
J Environ Pathol Toxicol Oncol, 30 (3), 235-40
DOI 10.1615/jenvironpatholtoxicoloncol.v30.i3.60, PubMed 22126616

Publications 2010

Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
J Photochem Photobiol B, 101 (2), 174-8
DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639

Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J (2010)
Influence of narrowband UVB phototherapy on vitamin D and folate status
Exp Dermatol, 19 (8), e67-72
DOI 10.1111/j.1600-0625.2009.00987.x, PubMed 19849714

Generalov R, Lukoseviciute S, Juzeniene A, Juzenas P (2010)
Cytotoxicity and Phototoxicity of Red Fluorescent Nontargeted Quantum Dots
IEEE J. Sel. Top. Quantum Electron., 16 (4), 997-1003
DOI 10.1109/JSTQE.2009.2034387

Grant WB, Juzeniene A, Moan JE (2010)
Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries
Scand J Public Health, 39 (1), 70-8
DOI 10.1177/1403494810382473, PubMed 20817654

Grant WB, Moan JE, Micu E, Porojnicu AC, Juzeniene A (2010)
Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers
Fam Cancer, 9 (4), 659-60; discussion 661-2
DOI 10.1007/s10689-010-9374-1, PubMed 20711817

Juzenas P, Juzeniene A (2010)
Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors
Photodiagnosis Photodyn Ther, 7 (3), 152-7
DOI 10.1016/j.pdpdt.2010.06.003, PubMed 20728838

Juzeniene A, Juzenas P, Iani V, Moan J (2010)
Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate
Photodiagnosis Photodyn Ther, 7 (4), 239-45
DOI 10.1016/j.pdpdt.2010.07.001, PubMed 21112546

Juzeniene A, Juzenas P, Moan J (2010)
Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo
Methods Mol Biol, 635, 97-106
DOI 10.1007/978-1-60761-697-9_7, PubMed 20552342

Juzeniene A, Ma LW, Kwitniewski M, Polev GA, Lagunova Z, Dahlback A, Moan J (2010)
The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D
Int J Infect Dis, 14 (12), e1099-105
DOI 10.1016/j.ijid.2010.09.002, PubMed 21036090

Juzeniene A, Stokke KT, Thune P, Moan J (2010)
Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure
J Photochem Photobiol B, 101 (2), 111-6
DOI 10.1016/j.jphotobiol.2010.01.013, PubMed 20207157

Kwitniewski M, Moan J, Juzeniene A (2010)
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy
Photochem Photobiol Sci, 10 (1), 25-8
DOI 10.1039/c0pp00193g, PubMed 20978658

Mikolajewska P, Donnelly RF, Garland MJ, Morrow DI, Singh TR, Iani V, Moan J, Juzeniene A (2010)
Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema
Pharm Res, 27 (10), 2213-20
DOI 10.1007/s11095-010-0227-2, PubMed 20676735

Moan J, Cicarma E, Setlow R, Porojnicu AC, Grant WB, Juzeniene A (2010)
Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation
Dermatoendocrinol, 2 (1), 3-8
DOI 10.4161/derm.2.1.11745, PubMed 21547141

Moan J, Juzeniene A (2010)
Solar radiation and human health
J Photochem Photobiol B, 101 (2), 109-10
DOI 10.1016/j.jphotobiol.2010.08.004, PubMed 20833325

Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
Seasonal variations of cancer incidence and prognosis
Dermatoendocrinol, 2 (2), 55-7
DOI 10.4161/derm.2.2.12664, PubMed 21547098

Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A (2010)
Where the sun does not shine: is sunshine protective against melanoma of the vulva?
J Photochem Photobiol B, 101 (2), 179-83
DOI 10.1016/j.jphotobiol.2010.03.003, PubMed 20359907

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses
J Pharm Sci, 99 (8), 3486-98
DOI 10.1002/jps.22116, PubMed 20222026

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Novel patch-based systems for the localised delivery of ALA-esters
J Photochem Photobiol B, 101 (1), 59-69
DOI 10.1016/j.jphotobiol.2010.06.012, PubMed 20634088

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches
J Pharm Pharmacol, 62 (6), 685-95
DOI 10.1211/jpp.62.06.0004, PubMed 20636855

Publications 2009

Cicarma E, Porojnicu AC, Lagunova Z, Dahlback A, Juzeniene A, Moan J (2009)
Sun and sun beds: inducers of vitamin D and skin cancer
Anticancer Res, 29 (9), 3495-500
PubMed 19667143

Cicarma E, Tuorkey M, Juzeniene A, Ma LW, Moan J (2009)
Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells
Br J Dermatol, 161 (2), 413-8
DOI 10.1111/j.1365-2133.2009.09180.x, PubMed 19438460

Donnelly RF, McCarron PA, Al-Kassas R, Juzeniene A, Juzenas P, Iani V, Woolfson AD, Moan J (2009)
Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles
Biopharm Drug Dispos, 30 (2), 55-70
DOI 10.1002/bdd.645, PubMed 19226650

Juzeniene A (2009)
Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis
Photodiagnosis Photodyn. Ther., 6 (2), 94-96
DOI 10.1016/j.pdpdt.2009.06.001

Juzeniene A, Kaliszewski M, Bugaj A, Moan J (2009)
Clearance of protoporphyrin IX induced by 5-aminolevulinic acid from WiDr human colon carcinoma cells
PROC SPIE, 7380, 73802Q
DOI 10.1117/12.822944

Juzeniene A, Setlow R, Porojnicu A, Steindal AH, Moan J (2009)
Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects
J Photochem Photobiol B, 96 (2), 93-100
DOI 10.1016/j.jphotobiol.2009.04.009, PubMed 19481954

Juzeniene A, Thu Tam TT, Iani V, Moan J (2009)
5-Methyltetrahydrofolate can be photodegraded by endogenous photosensitizers
Free Radic Biol Med, 47 (8), 1199-204
DOI 10.1016/j.freeradbiomed.2009.07.030, PubMed 19647791

Kwitniewski M, Jankowski D, Jaskiewicz K, Dziadziuszko H, Juzeniene A, Moan J, Ma LW, Peksa R, Kunikowska D, Graczyk A, Kwasny M, Kaliszewski M, Glosnicka R (2009)
Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin
Int J Cancer, 125 (7), 1721-7
DOI 10.1002/ijc.24488, PubMed 19521986

Mikolajewska P, Iani V, Juzeniene A, Moan J (2009)
Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema
Br J Dermatol, 161 (5), 1173-9
DOI 10.1111/j.1365-2133.2009.09437.x, PubMed 19785604

Mikolajewska P, Juzeniene A, Iani V, Sollund H, Norsang G, Moan J (2009)
A pilot study comparing the pain sensations during PpIX build-up and clearance phases
PROC SPIE, 7380, 73802Y
DOI 10.1117/12.822949

Moan J, Dahlback A, Ma L, Juzeniene A (2009)
Influenza, solar radiation and vitamin D
Dermatoendocrinol, 1 (6), 307-9
DOI 10.4161/derm.1.6.11357, PubMed 21572876

Pudroma X, Moan J, Ma LW, Iani V, Juzeniene A (2009)
A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin
Exp Dermatol, 18 (11), 985-7
DOI 10.1111/j.1600-0625.2009.00863.x, PubMed 19469901

Publications 2008

Donnelly RF, Morrow DI, McCarron PA, David Woolfson A, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer
Photochem Photobiol, 85 (1), 195-204
DOI 10.1111/j.1751-1097.2008.00417.x, PubMed 18764907

Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy
J Control Release, 129 (3), 154-62
DOI 10.1016/j.jconrel.2008.05.002, PubMed 18556084

Juzenas P, Generalov R, Juzeniene A, Moan J (2008)
Generation of Nitrogen Oxide and Oxygen Radicals by Quantum Dots
J. Biomed. Nanotechnol., 4 (4), 450-456
DOI 10.1166/jbn.2008.008

Juzenas P, Juzeniene A, Iani V, Moan J (2008)
Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model
Photochem Photobiol, 85 (3), 760-4
DOI 10.1111/j.1751-1097.2008.00496.x, PubMed 19140894

Juzeniene A, Nielsen KP, Zhao L, Ryzhikov GA, Biryulina MS, Stamnes JJ, Stamnes K, Moan J (2008)
Changes in human skin after topical PDT with hexyl aminolevulinate
Photodiagnosis Photodyn Ther, 5 (3), 176-81
DOI 10.1016/j.pdpdt.2008.07.001, PubMed 19356652

Peng Q, Juzeniene A, Chen J, Svaasand LO, Warloe T, Giercksky KE, Moan J (2008)
Lasers in medicine
Rep. Prog. Phys., 71 (5), 056701
DOI 10.1088/0034-4885/71/5/056701

Steindal AH, Tam TT, Lu XY, Juzeniene A, Moan J (2008)
5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin
Photochem Photobiol Sci, 7 (7), 814-8
DOI 10.1039/b718907a, PubMed 18597029

Wold JP, Veberg Dahl A, Lundby F, Nilsen AN, Juzeniene A, Moan J (2008)
Effect of oxygen concentration on photo-oxidation and photosensitizer bleaching in butter
Photochem Photobiol, 85 (3), 669-76
DOI 10.1111/j.1751-1097.2008.00492.x, PubMed 19140897

Publications 2007

Bugaj A, Kwitniewski M, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2007)
Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice
Photodiagnosis Photodyn Ther, 4 (4), 237-41
DOI 10.1016/j.pdpdt.2007.08.001, PubMed 25047558

Gonzalez H, Tarras-Wahlberg N, Strömdahl B, Juzeniene A, Moan J, Larkö O, Rosén A, Wennberg AM (2007)
Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps
BMC Dermatol, 7, 1
DOI 10.1186/1471-5945-7-1, PubMed 17324264

Juzeniene A, Juzenas P, Iani V, Moan J (2007)
Topical applications of iron chelators in photosensitization
Photochem Photobiol Sci, 6 (12), 1268-74
DOI 10.1039/b703861e, PubMed 18046481

Juzeniene A, Peng Q, Moan J (2007)
Milestones in the development of photodynamic therapy and fluorescence diagnosis
Photochem Photobiol Sci, 6 (12), 1234-45
DOI 10.1039/b705461k, PubMed 18046478

Mikolajewska P, Juzeniene A, Moan J (2007)
The effect of lidocaine on PpIX photobleaching and outcome of ALA-PDT in vitro
Photodiagnosis Photodyn Ther, 4 (4), 249-53
DOI 10.1016/j.pdpdt.2007.10.002, PubMed 25047561

Publications 2006

Bugaj A, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2006)
The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac(®)CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study
Photodiagnosis Photodyn Ther, 3 (1), 27-33
DOI 10.1016/S1572-1000(05)00109-2, PubMed 25049025

Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J (2006)
The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
J Photochem Photobiol B, 84 (2), 161-6
DOI 10.1016/j.jphotobiol.2006.02.009, PubMed 16624569

Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2006)
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
Br J Dermatol, 155 (4), 791-9
DOI 10.1111/j.1365-2133.2006.07484.x, PubMed 16965430

Juzeniene A, Moan J (2006)
The history of PDT in Norway Part one: Identification of basic mechanisms of general PDT
Photodiagnosis Photodyn Ther, 4 (1), 3-11
DOI 10.1016/j.pdpdt.2006.11.002, PubMed 25047184

Juzeniene A, Moan J (2006)
The history of PDT in Norway Part II. Recent advances in general PDT and ALA-PDT
Photodiagnosis Photodyn Ther, 4 (2), 80-7
DOI 10.1016/j.pdpdt.2006.11.001, PubMed 25047338

Juzeniene A, Nielsen KP, Moan J (2006)
Biophysical aspects of photodynamic therapy
J Environ Pathol Toxicol Oncol, 25 (1-2), 7-28
DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.20, PubMed 16566708

Publications 2005

Kaliszewski M, Juzeniene A, Juzenas P, Kwasny M, Kaminski J, Dabrowski Z, Golinski J, Moan J (2005)
Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid
Photodiagnosis Photodyn Ther, 2 (2), 129-34
DOI 10.1016/S1572-1000(05)00012-8, PubMed 25048672

Publications 2004

Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004)
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
Lasers Med Sci, 19 (3), 139-49
DOI 10.1007/s10103-004-0314-x, PubMed 15503248

Publications 2002

Juzeniene A, Juzenas P, Iani V, Moan J (2002)
Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model
Photochem Photobiol, 76 (3), 329-34
DOI 10.1562/0031-8655(2002)076<0329:taoaaa>2.0.co;2, PubMed 12403455

Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002)
Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin
Photochem Photobiol, 76 (4), 452-6
DOI 10.1562/0031-8655(2002)076<0452:teoaop>2.0.co;2, PubMed 12405155

Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002)
Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo
Cell Mol Biol (Noisy-le-grand), 48 (8), 911-6
PubMed 12699250